GSK Salbutamol Programme

Project Description:

M2 Build is an Oral Solid Dose facility (OSD), producing tablets and capsules for the GSK brand. 

The project was a blend of modular design (DFMA) and traditional ‘stick built’ construction.

Key Challenges:

Providing a GMP environment

DFMA Modular Design

Should you wish to know more about our role on Science, Research and Healthcare projects, please contact hello@iM2ltd.com

iM2 Role: Principal Designer

​

Project Team:

Client: GSK

Architect: Simons Design Ltd

Engineer: Shepherd Gilmore

MEP: NG Bailey

PC: GSK

​

Start Date: July 2020

​

Completion: January 2023

​

Value: (£) Confidential